FTXH ETF
First Trust Nasdaq Pharmaceuticals ETF
ABBV is FTXH's largest holding at 7.46% of the fund as of Oct 2, 2026. FTXH is First Trust Nasdaq Pharmaceuticals ETF.
| # | Ticker | Name | Weight | Cumulative | Shares | Mkt value | Share chg | Sector | Industry |
|---|---|---|---|---|---|---|---|---|---|
| 1 | A | AbbVie IncHealth Care · Pharmaceuticals | 7.46% | 7.5% | 297,116 | $78.09M | +6.7K | Health Care | Pharmaceuticals |
| 2 | L | Eli Lilly & Co.Health Care · Pharmaceuticals | 7.19% | 14.7% | 65,864 | $75.27M | +2.0K | Health Care | Pharmaceuticals |
| Share changes, sector and industry · Pro | |||||||||
| 3 | M | Merck & Co. Inc. | 7.11% | 21.8% | 515,611 | $74.40M | |||
| 4 | P | Pfizer, Inc. | 7.11% | 28.9% | 2,676,971 | $74.42M | |||
| 5 | J | Johnson & Johnson | 7.01% | 35.9% | 286,578 | $73.37M | |||
| 6 | V | Viatris Inc | 3.88% | 39.8% | 2,307,287 | $40.61M | |||
| 7 | B | Biogen Inc | 3.69% | 43.5% | 175,830 | $38.66M | |||
| 8 | G | Gilead Sciences Inc | 3.60% | 47.1% | 260,308 | $37.68M | |||
| 9 | U | United Therapeutics Corp | 3.43% | 50.5% | 66,257 | $35.89M | |||
| 10 | A | Amgen Inc | 3.41% | 53.9% | 88,614 | $35.71M | |||
| 11 | I | Incyte Corp | 3.37% | 57.3% | 305,699 | $35.25M | |||
| 12 | — | Vertex Pharmaceuticals Inc | 3.37% | 60.6% | 69,957 | $35.31M | |||
| 13 | R | Regeneron Pharmaceuticals | 3.35% | 64.0% | 47,671 | $35.05M | |||
| 14 | B | Bristol Myers Squibb Co | 3.33% | 67.3% | 570,174 | $34.87M | |||
| 15 | Z | Zoetis, Inc. | 3.29% | 70.6% | 494,077 | $34.43M | |||
| 16 | J | Jazz Pharmaceuticals Plc | 2.73% | 73.3% | 121,105 | $28.54M | |||
| 17 | E | Exelixis Inc | 2.37% | 75.7% | 424,333 | $24.78M | |||
| 18 | I | Illumina Inc. | 2.30% | 78.0% | 87,980 | $24.02M | |||
| 19 | H | Halozyme Therapeutics Inc | 1.61% | 79.6% | 152,933 | $16.80M | |||
| 20 | M | Medpace Holdings Inc | 1.50% | 81.1% | 26,245 | $15.73M | |||
| 21 | N | Neurocrine Biosciences Inc | 1.23% | 82.3% | 90,007 | $12.89M | |||
| 22 | B | Biomarin Pharmaceutical Inc. | 1.22% | 83.6% | 223,082 | $12.76M | |||
| 23 | E | Elanco Animal Health | 1.16% | 84.7% | 546,432 | $12.10M | |||
| 24 | A | Alnylam Pharmac.. | 1.15% | 85.9% | 54,565 | $11.99M | |||
| 25 | C | Charles River Laboratories | 1.02% | 86.9% | 36,852 | $10.69M | |||
| 26 | I | Iovance Biotherapeutics Inc | 0.88% | 87.8% | 648,101 | $9.21M | |||
| 27 | T | 10x Genomics Inc Com Usd 1 Cl A | 0.76% | 88.5% | 84,787 | $7.93M | |||
| 28 | M | Moderna Inc | 0.69% | 89.2% | 37,730 | $7.17M | |||
| 29 | T | Twist Bioscience Corp. | 0.69% | 89.9% | 38,093 | $7.19M | |||
| 30 | A | Amneal Pharmaceuticals Inc Com Stk Cl A | 0.59% | 90.5% | 303,091 | $6.15M | |||
| 31 | A | Adaptive Biotechnologies Corp | 0.58% | 91.1% | 212,478 | $6.02M | |||
| 32 | G | Guardant Health Inc | 0.57% | 91.7% | 33,297 | $5.92M | |||
| 33 | — | Caris Life Sciences, Inc | 0.56% | 92.2% | 207,728 | $5.88M | |||
| 34 | L | Ligand Pharmaceuticals Inc | 0.54% | 92.8% | 18,638 | $5.65M | |||
| 35 | S | Spyre Therapeutics Inc | 0.53% | 93.3% | 59,275 | $5.52M | |||
| 36 | C | Corcept Therapeutics Inc | 0.52% | 93.8% | 46,713 | $5.43M | |||
| 37 | — | Roivant Sciences Ltd. Common Shares | 0.52% | 94.3% | 152,857 | $5.46M | |||
| 38 | T | Tango Therapeutics Inc. | 0.51% | 94.8% | 231,829 | $5.39M | |||
| 39 | T | Tg Therapeutics Inc | 0.51% | 95.3% | 97,514 | $5.29M | |||
| 40 | P | Protagonist Therapeutics Inc | 0.48% | 95.8% | 35,837 | $5.02M | |||
| 41 | K | Kymera Therapeutics Inc | 0.46% | 96.3% | 44,566 | $4.79M | |||
| 42 | O | Oruka Therapeutics Inc Orka | 0.46% | 96.7% | 57,169 | $4.83M | |||
| 43 | K | Krystal Biotech Inc | 0.45% | 97.2% | 14,734 | $4.75M | |||
| 44 | — | Alkermes Plc. Ordinary Shares | 0.45% | 97.6% | 112,683 | $4.70M | |||
| 45 | T | Travere Therapeutics Inc | 0.43% | 98.1% | 79,888 | $4.55M | |||
| 46 | D | Dianthus Therapeutics Inc | 0.42% | 98.5% | 50,138 | $4.42M | |||
| 47 | E | Enliven Therapeutics Inc | 0.41% | 98.9% | 91,465 | $4.30M | |||
| 48 | A | Arrowhead Pharmaceuticals Inc | 0.39% | 99.3% | 64,267 | $4.13M | |||
| 49 | A | Acadia Pharmaceuticals Inc | 0.35% | 99.6% | 183,153 | $3.65M | |||
| 50 | — | Liquidia Technologies Inc | 0.21% | 99.9% | 77,673 | $2.22M | |||
| More holdings · Pro | |||||||||
FTXH ETF All Holdings
FTXH holdings total 100 positions. The top 10 holdings account for 53.9% of the fund, led by Abbvie Inc at 7.5%, Eli Lilly & Co. at 7.2%, Merck & Co. Inc. at 7.1%.
FTXH portfolio concentration is relatively high, with the top 10 representing 53.9% of total assets. The largest sector exposure is Health Care at 95.9%.
FTXH sectors provide a detailed breakdown. FTXH overlap shows how holdings compare to other funds in your portfolio.
FTXH ETF Holdings
51 of 100 holdings
- 1
Abbvie Inc
ABBVHealth Care7.46% - 2
Eli Lilly & Co.
LLYHealth Care7.19% - 3
Merck & Co. Inc.
MRKHealth Care7.11% - 4
Pfizer, Inc.
PFEHealth Care7.11% - 5
Johnson & Johnson
JNJHealth Care7.01% - 6
Viatris Inc
VTRSHealth Care3.88% - 7
Biogen Inc
BIIBHealth Care3.69% - 8
Gilead Sciences Inc
GILDHealth Care3.60% - 9
United Therapeutics Corp
UTHRHealth Care3.43% - 10
Amgen Inc
AMGNHealth Care3.41% - 11
Incyte Corp
INCYHealth Care3.37% - 12
Vertex Pharmaceuticals Incorporated
VRTX:MXUnknown3.37% - 13
Regeneron Pharmaceuticals
REGNHealth Care3.35% - 14
Bristol Myers Squibb Co
BMYHealth Care3.33% - 15
Zoetis, Inc.
ZTSHealth Care3.29% - 16
Jazz Pharmaceuticals Plc
JAZZHealth Care2.73% - 17
Exelixis Inc
EXELHealth Care2.37% - 18
Illumina Inc.
ILMNHealth Care2.30% - 19
Halozyme Therapeutics Inc
HALOHealth Care1.61% - 20
Medpace Holdings Inc
MEDPHealth Care1.50% - 21
Neurocrine Biosciences Inc
NBIXHealth Care1.23% - 22
Biomarin Pharmaceutical Inc.
BMRNHealth Care1.22% - 23
Elanco Animal Health
ELANHealth Care1.16% - 24
Alnylam Pharmac..
ALNYHealth Care1.15% - 25
Charles River Laboratories
CRLHealth Care1.02% - 26
Iovance Biotherapeutics Inc
IOVAHealth Care0.88% - 27
10x Genomics Inc Com Usd 1 Cl A
TXGHealth Care0.76% - 28
Moderna Inc
MRNAHealth Care0.69% - 29
Twist Bioscience Corp.
TWSTHealth Care0.69% - 30
Amneal Pharmaceuticals Inc Com Stk Cl A
AMRXHealth Care0.59% - 31
Adaptive Biotechnologies Corporation
ADPTUnknown0.58% - 32
Guardant Health Inc
GHHealth Care0.57% - 33
Caris Life Sciences, Inc
CAIHealth Care0.56% - 34
Ligand Pharmaceuticals Incorporated
LGNDHealth Care0.54% - 35
Spyre Therapeutics Inc
SYREHealth Care0.53% - 36
Corcept Therapeutics Inc
CORTHealth Care0.52% - 37
Roivant Sciences Ltd. Common Shares
ROIV:BMHealth Care0.52% - 38
Tango Therapeutics Inc.
TNGXHealth Care0.51% - 39
Tg Therapeutics Inc Common Stock
TGTXHealth Care0.51% - 40
Protagonist Therapeutics Inc
PTGXHealth Care0.48% - 41
Kymera Therapeutics Inc
KYMRHealth Care0.46% - 42
Oruka Therapeutics Inc Orka
ORKAHealth Care0.46% - 43
Krystal Biotech Inc
KRYSHealth Care0.45% - 44
Alkermes Plc. Ordinary Shares
ALKS:IEHealth Care0.45% - 45
Travere Therapeutics Inc
TVTXHealth Care0.43% - 46
Dianthus Therapeutics Inc
DNTHHealth Care0.42% - 47
Enliven Therapeutics Inc
ELVNHealth Care0.41% - 48
Arrowhead Pharmaceuticals Inc
ARWRHealth Care0.39% - 49
Acadia Pharmaceuticals Inc
ACADHealth Care0.35% - 50
Liquidia Technologies Inc
LQDAHealth Care0.21% - 51
USD
Other0.15%
| # | Company | Ticker | Sector | Industry | Weight |
|---|---|---|---|---|---|
| 1 | Abbvie Inc | ABBV | 7.460% | ||
| 2 | Eli Lilly & Co. | LLY | 7.190% | ||
| 3 | Merck & Co. Inc. | MRK | 7.110% | ||
| 4 | Pfizer, Inc. | PFE | 7.110% | ||
| 5 | Johnson & Johnson | JNJ | 7.010% | ||
| 6 | Viatris Inc | VTRS | 3.880% | ||
| 7 | Biogen Inc | BIIB | 3.690% | ||
| 8 | Gilead Sciences Inc | GILD | 3.600% | ||
| 9 | United Therapeutics Corp | UTHR | 3.430% | ||
| 10 | Amgen Inc | AMGN | 3.410% | ||
| 11 | Incyte Corp | INCY | 3.370% | ||
| 12 | Vertex Pharmaceuticals Incorporated | VRTX:MX | 3.370% | ||
| 13 | Regeneron Pharmaceuticals | REGN | 3.350% | ||
| 14 | Bristol Myers Squibb Co | BMY | 3.330% | ||
| 15 | Zoetis, Inc. | ZTS | 3.290% | ||
| 16 | Jazz Pharmaceuticals Plc | JAZZ | 2.730% | ||
| 17 | Exelixis Inc | EXEL | 2.370% | ||
| 18 | Illumina Inc. | ILMN | 2.300% | ||
| 19 | Halozyme Therapeutics Inc | HALO | 1.610% | ||
| 20 | Medpace Holdings Inc | MEDP | 1.500% | ||
| 21 | Neurocrine Biosciences Inc | NBIX | 1.230% | ||
| 22 | Biomarin Pharmaceutical Inc. | BMRN | 1.220% | ||
| 23 | Elanco Animal Health | ELAN | 1.160% | ||
| 24 | Alnylam Pharmac.. | ALNY | 1.150% | ||
| 25 | Charles River Laboratories | CRL | 1.020% | ||
| 26 | Iovance Biotherapeutics Inc | IOVA | 0.880% | ||
| 27 | 10x Genomics Inc Com Usd 1 Cl A | TXG | 0.760% | ||
| 28 | Moderna Inc | MRNA | 0.690% | ||
| 29 | Twist Bioscience Corp. | TWST | 0.690% | ||
| 30 | Amneal Pharmaceuticals Inc Com Stk Cl A | AMRX | 0.590% | ||
| 31 | Adaptive Biotechnologies Corporation | ADPT | 0.580% | ||
| 32 | Guardant Health Inc | GH | 0.570% | ||
| 33 | Caris Life Sciences, Inc | CAI | 0.560% | ||
| 34 | Ligand Pharmaceuticals Incorporated | LGND | 0.540% | ||
| 35 | Spyre Therapeutics Inc | SYRE | 0.530% | ||
| 36 | Corcept Therapeutics Inc | CORT | 0.520% | ||
| 37 | Roivant Sciences Ltd. Common Shares | ROIV:BM | 0.520% | ||
| 38 | Tango Therapeutics Inc. | TNGX | 0.510% | ||
| 39 | Tg Therapeutics Inc Common Stock | TGTX | 0.510% | ||
| 40 | Protagonist Therapeutics Inc | PTGX | 0.480% | ||
| 41 | Kymera Therapeutics Inc | KYMR | 0.460% | ||
| 42 | Oruka Therapeutics Inc Orka | ORKA | 0.460% | ||
| 43 | Krystal Biotech Inc | KRYS | 0.450% | ||
| 44 | Alkermes Plc. Ordinary Shares | ALKS:IE | 0.450% | ||
| 45 | Travere Therapeutics Inc | TVTX | 0.430% | ||
| 46 | Dianthus Therapeutics Inc | DNTH | 0.420% | ||
| 47 | Enliven Therapeutics Inc | ELVN | 0.410% | ||
| 48 | Arrowhead Pharmaceuticals Inc | ARWR | 0.390% | ||
| 49 | Acadia Pharmaceuticals Inc | ACAD | 0.350% | ||
| 50 | Liquidia Technologies Inc | LQDA | 0.210% | ||
| 51 | USD | - | 0.150% |












































